40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland by Herrmann, Christian et al.
RESEARCH ARTICLE Open Access
40 years of progress in female cancer death
risk: a Bayesian spatio-temporal mapping
analysis in Switzerland
Christian Herrmann1,2,3*, Silvia Ess1, Beat Thürlimann4,5, Nicole Probst-Hensch2,3 and Penelope Vounatsou2,3
Abstract
Background: In the past decades, mortality of female gender related cancers declined in Switzerland and other
developed countries. Differences in the decrease and in spatial patterns within Switzerland have been reported
according to urbanisation and language region, and remain controversial. We aimed to investigate geographical
and temporal trends of breast, ovarian, cervical and uterine cancer mortality, assess whether differential trends exist
and to provide updated results until 2011.
Methods: Breast, ovarian, cervical and uterine cancer mortality and population data for Switzerland in the period
1969–2011 was retrieved from the Swiss Federal Statistical office (FSO). Cases were grouped into <55 year olds,
55–74 year olds and 75+ year olds. The geographical unit of analysis was the municipality.
To explore age- specific spatio-temporal patterns we fitted Bayesian hierarchical spatio-temporal models on
subgroup-specific death rates indirectly standardized by national references. We used linguistic region and degree
of urbanisation as covariates.
Results: Female cancer mortality continuously decreased in terms of rates in all age groups and cancer sites except
for ovarian cancer in 75+ year olds, especially since 1990 onwards.
Contrary to other reports, we found no systematic difference between language regions. Urbanisation as a proxy
for access to and quality of medical services, education and health consciousness seemed to have no influence on
cancer mortality with the exception of uterine and ovarian cancer in specific age groups. We observed no obvious
spatial pattern of mortality common for all cancer sites.
Rate reduction in cervical cancer was even stronger than for other cancer sites.
Conclusions: Female gender related cancer mortality is continuously decreasing in Switzerland since 1990.
Geographical differences are small, present on a regional or canton-overspanning level, and different for each
cancer site and age group. No general significant association with cantonal or language region borders could be
observed.
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Background
Female gender related cancers, in particular cancer of
the breast, corpus uteri, ovary and cervix uteri account
for more than 40 % of newly diagnosed cancers and for
about 30 % of cancer related deaths in Swiss women [1].
In the past decades, female cancer mortality declined in
Switzerland and the more developed countries [1]
mainly due to advances in the understanding of tumour
biology and in early detection, as well as the introduc-
tion of targeted therapies. However, differences in the
decrease within Switzerland have been reported, such as
for breast cancer in four selected cantons [2].
Switzerland is a small, affluent and culturally diverse
confederation of 26 relatively autonomous states called
cantons. Health care policies are developed at cantonal
level resulting in a large geographical variation in health
expenditures, control programs and care planning. I.e.
population based mammography screening programs
were and are implemented at very different time points
over a period of more than 20 years in the various can-
tons. Most studies, including the above, investigated dif-
ferences on the same regional level –cantons–, but it
remained unknown whether these are consistent geo-
graphical disparities related to cantonal decisions or ar-
tefacts due to the choice of geographical and time units;
driven by sub regions or complete region. The only
more detailed maps of female cancer mortality rates are
those of Schüler and Bopp [3] depicting geographical
variation in mortality during 1970–1990 on the basis of
so called MS-regions, 106 ‘unofficial’ regions smaller
than cantons defined by mobility considerations. Since
they have not applied temporal and geographical smooth-
ing, the results may be distorted especially in areas where
the population is small. This makes it difficult to distin-
guish chance variability from real differences. To our
knowledge, covariate-adjusted and smooth, nationwide
maps of female cancer mortality depicting the changes
over time and space are not available.
Therefore, we studied geographical and temporal
trends of breast, ovarian, cervical and uterine cancer
mortality in Switzerland, adding 20 years of data to pre-
vious work, using state-of-the-art methodology for re-
sults with more detail and fewer artefacts, and without
prejudice of geographical unit or shape of time trends.
Hence, we used the most detailed available data (munici-
pality level) and accounted for non-linear time trends.
We hypothesized similar patterns for the different can-
cer sites and/or age group. Bayesian spatial models are
the state-of-the-art modelling approach for assessing
spatio-temporal patterns and trends. They “smooth” or
improve estimation of an unstable rate by “borrowing”
strength from its neighbours [4]. They can also assess
the significance of risk factors taking into account the
geographical correlation, and are able to show spatial
patterns after adjustment for geographical differences in
certain risk factors.
Methods
Data sources
Female cancer mortality data was obtained for the
period 1969–2011 from death certificates coded centrally
by the Swiss Federal Statistical office (FSO). The data in-
clude age at death, year of birth and death for each indi-
vidual, nationality, municipality of residence, the cause
of death and co-morbidities. Cause of death and co-
morbidities are coded using the 8th revision of the
International Classification of Diseases (ICD) until 1994/
1995 and afterwards using the 10th revision. The transi-
tion to the 10th revision of the ICD-10 was accompanied
by changes in death certificate coding practices (priority
rules). We used age- and cancer site-specific correction
factors as proposed by Lutz et al. [5] for the death counts.
We included all cases coded with main causes of death
being cancer of the female breast (ICD-10 C50.0-C50.9),
cervix (ICD-10 C53.0- C53.9), corpus uterine (ICD-10
C54.0-C55.9) and ovary (ICD-10 C56.9). According to
federal regulations, mortality data excluding any identi-
fiable information can be used in epidemiological stud-
ies without additional ethics committee approval.
Detailed population data on municipality level is only
available from census that takes place in Switzerland
every 10 years with the last one taking place in 2010.
We aggregated the mortality data in five 4-year periods
around the census years, i.e. 1969–1972, 1979–1982,
1989–1992, 1999–2002 and 2008–2011, in which popu-
lation was assumed to be constant.
There are around 2,500 municipalities in the country.
Over the study period, the number of municipalities has
changed due to fusion, separation, deletion or new oc-
currences. We aligned all data on the 2011 municipality
structure using spatial data for 2011 and municipality
transition protocols for each year obtained from the
FSO. From the same source, we retrieved data on lan-
guage region (German, French and Italian/Romansh)
and urbanisation (Fig. 1). We grouped municipalities
classified as central agglomeration city, greater agglom-
eration and isolated city into “urban” leaving the classifi-
cation “rural” unchanged.
Statistical methods
Age was grouped into three groups (<55, 55–74, 75+
year olds). The geographical unit of analysis was the
municipality.
In a preliminary analysis, we investigated SMR ratio
values in a non-spatial model. Spatio-temporal Poisson
and negative binomial regression models were fitted sep-
arately for each age group on the number of deaths ag-
gregated by municipality and year with the mean being
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Fig. 1 Urbanization classification and language regions in Switzerland
Table 1 Female cancer mortality in Switzerland by age group and time period corrected for coding changes
Aged <55 Aged 55-74 Aged 75+
Period Total number of cases Rate per 100,000 PY Total number of cases Rate per 100,000 PY Total number of cases Rate per 100,000 PY
Breast cancer
1969-1972 995 10.3 2,185 89.5 997 161.6
1979-1982 1,062 11.1 2,336 92.6 1,556 169.5
1989-1992 1,110 11.0 2,345 89.0 2,512 210.6
1999-2002 908 8.6 2,184 74.9 2,169 159.4
2007-2010 813 7.4 2,303 68.1 2,501 160.9
Cervical cancer
1969-1972 324 3.3 465 19.1 186 30.1
1979-1982 227 2.4 389 15.4 212 23.1
1989-1992 155 1.5 244 9.3 205 17.2
1999-2002 84 0.8 127 4.4 144 10.6
2007-2010 80 0.7 112 3.3 124 8.0
Uterine cancer
1969-1972 114 1.2 693 28.4 340 55.1
1979-1982 66 0.7 498 19.7 458 49.9
1989-1992 46 0.5 416 15.8 607 50.9
1999-2002 53 0.5 326 11.2 457 33.6
2007-2010 43 0.4 316 9.3 467 30.1
Ovarian cancer
1969-1972 321 3.3 823 33.7 304 49.3
1979-1982 281 2.9 892 35.3 496 54.1
1989-1992 224 2.2 816 31.0 718 60.2
1999-2002 165 1.6 713 24.4 717 52.7
2007-2010 165 1.5 790 23.3 775 49.9
PY Person Years
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equal to the product of the expected death count and
age standardised mortality rate. Indirect standardisation
used 5 years age intervals. Expected mortality counts for
each municipality, year and age group were obtained
from the study population using nationwide age-specific
mortality rates for all periods.
Space and temporal random effects as well as possible
non-linear temporal trends were modelled on the log of the
mean standardised mortality rate following model
formulations of Jürgens et al. [6] (cf. Appendix 1). In par-
ticular, municipality-specific random effects were modelled
via conditional autoregressive (CAR) models to filter out
the noise and highlight the observed patterns. The models
were formulated as hierarchical Bayesian models with par-
ameter estimation via Markov chain Monte Carlo simula-
tion (MCMC). We used the Deviance Information
Criterion (DIC) to select the regression models from Pois-
son/Negative binomial regression with or without an
Table 2 Spatio-temporal model estimates of age specific female cancer mortality in Switzerland from 1969–1972 to 2007-2010
SMR Ratio (95 % Bayesian Credible Interval) SMR Ratio (95 % Bayesian Credible Interval)
Age group <55 55-74 75+ Age group <55 55-74 75+
Breast cancer Uterine cancer
Period Period
1969-1972 1.00 1.00 1.00 1969-1972 1.00 1.00 1.00
1979-1982 0.97 (0.89;1.06) 1.03 (0.97;1.09) 1.03 (0.95;1.12) 1979-1982 0.52 (0.38;0.71) 0.68 (0.61;0.76) 0.89 (0.77;1.03)
1989-1992 0.90 (0.83;0.98) 1.00 (0.94;1.06) 1.22 (1.14;1.32) 1989-1992 0.33 (0.23;0.45) 0.55 (0.49;0.63) 0.88 (0.77;1.02)
1999-2002 0.64 (0.59;0.70) 0.84 (0.80;0.89) 0.91 (0.84;0.98) 1999-2002 0.32 (0.23;0.45) 0.39 (0.35;0.45) 0.57 (0.49;0.66)
2007-2010 0.50 (0.46;0.55) 0.77 (0.73;0.81) 0.91 (0.84;0.98) 2007-2010 0.23 (0.16;0.33) 0.33 (0.29;0.38) 0.51 (0.44;0.59)
Language Language
German 1.00 1.00 1.00 German 1.00 1.00 1.00
French 1.09 (0.89;1.32) 0.95 (0.83;1.09) 1.07 (0.92;1.25) French 1.16 (0.73;1.89) 1.25 (0.99;1.63) 1.00 (0.79;1.29)
Italian/Roman. 0.96 (0.71;1.34) 0.97 (0.77;1.22) 1.01 (0.80;1.29) Italian/Roman. 1.10 (0.44;2.43) 0.92 (0.57;1.40) 0.93 (0.59;1.44)
Urbanisation level Urbanisation level
Rural 1.00 1.00 1.00 Rural 1.00 1.00 1.00
Urban 1.08 (1.00;1.18) 1.04 (0.99;1.10) 1.01 (0.96;1.07) Urban 0.99 (0.76;1.33) 0.89 (0.81;0.99) 1.00 (0.89;1.11)
Cervical cancer Ovarian cancer
Period Period
1969-1972 1.00 1.00 1.00 1969-1972 1.00 1.00 1.00
1979-1982 0.65 (0.55;0.77) 0.80 (0.70;0.91) 0.76 (0.62;0.92) 1979-1982 0.81 (0.69;0.95) 1.04 (0.94;1.14) 1.09 (0.94;1.25)
1989-1992 0.39 (0.32;0.46) 0.49 (0.41;0.58) 0.55 (0.45;0.68) 1989-1992 0.57 (0.48;0.68) 0.91 (0.83;1.00) 1.20 (1.05;1.38)
1999-2002 0.18 (0.14;0.23) 0.23 (0.19;0.28) 0.34 (0.27;0.41) 1999-2002 0.37 (0.30;0.44) 0.73 (0.66;0.81) 1.06 (0.92;1.21)
2007-2010 0.15 (0.12;0.20) 0.18 (0.14;0.22) 0.25 (0.20;0.31) 2007-2010 0.32 (0.26;0.38) 0.70 (0.63;0.77) 1.00 (0.88;1.14)
Language Language
German 1.00 1.00 1.00 German 1.00 1.00 1.00
French 0.98 (0.70;1.35) 0.97 (0.69;1.30) 0.95 (0.67;1.37) French 0.91 (0.68;1.25) 0.98 (0.81;1.18) 0.93 (0.74;1.16)
Italian/Roman. 0.81 (0.41;1.45) 1.08 (0.64;1.75) 1.47 (0.81;2.78) Italian/Roman. 1.17 (0.64;1.92) 1.00 (0.71;1.39) 0.72 (0.50;1.06)
Urbanisation level Urbanisation level
Rural 1.00 1.00 1.00 Rural 1.00 1.00 1.00
Urban 1.11 (0.94;1.33) 1.07 (0.92;1.24) 1.03 (0.87;1.23) Urban 0.85 (0.74;0.99) 1.04 (0.96;1.13) 1.13 (1.02;1.25)
Spatial variation (95 % Bayesian Credible Interval) Spatial variation (95 % Bayesian Credible Interval)
Age group <55 55-74 75+ Age group <55 55-74 75+
Breast cancer 0.27 (0.22;0.33) 0.23 (0.19;0.27) 0.25 (0.21;0.29) Uterine cancer 0.46 (0.32;0.67) 0.35 (0.28;0.44) 0.33 (0.26;0.43)
Cervical cancer 0.41 (0.32;0.54) 0.36 (0.28;0.47) 0.41 (0.31;0.54) Ovarian cancer 0.36 (0.27;0.46) 0.29 (0.24;0.36) 0.32 (0.26;0.41)
Results from model 1 (cf. Table 3). Bold values denote Age-Standardized Mortality-Ratio (SMR) Ratios significantly different from 1. Spatial variation (standard
deviation of spatial random effects): a value of 0 means that there is no spatial correlation
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additional set of unstructured random effects for each
municipality.
Data on language and urbanisation were included as co-
variates in the model. These analyses will indicate whether
there are statistically significant differences in the cancer
mortality for each one of the above covariates, assessed by
95 % Bayesian Credible Intervals (CI).
From the estimates of the model, we produced smoothed
maps displaying geographical patterns of female gen-
der cancer mortality for each age group, cancer site
and year since 1969 till recent almost to date.
Results
Table 1 shows the number of female cancer deaths and
crude rates per 100,000 person years in Switzerland by
age group within the 4-year periods under investigation.
Among the cancer sites studied, breast cancer was the
most common cause of death, followed by ovarian, uter-
ine and cervical cancer.
Mortality rates continuously decreased for cervical and
uterine cancer, and for ovarian cancer in the <55 year olds.
For breast cancer and the other age groups of ovarian can-
cer, mortality rates decreased only as from 1979–1982 and
from 1989–1992 for 75+ year olds respectively.
Table 2 shows the results of the spatio-temporal
regression analysis by cancer site and age group. With the
spatial analysis, we could confirm the time trends observed
in the crude rates in Table 1, while only in few cases the co-
variates had a significant effect on the standardized mortal-
ity ratio (SMR). Language region had in none of the models
a significant effect on mortality, urbanisation only in 3
models: An urban environment was associated with a sig-
nificantly lower mortality of 55–74 year olds in uterine can-
cer and <55 year olds in ovarian cancer, and associated with
higher ovarian cancer mortality in 75+ year olds.
In the elderly (75+ year olds), a significant increase
in breast and ovarian cancer mortality until 1989–
1992 was observed and decreasing only since then
(Tables 1 and 2).
Fig. 2 Trends and geographical distribution of age standardized breast cancer mortality (SMR) by age group and among selected time periods.
Values are calculated and smoothed in relation to the cancer site and age specific all period combined mortality. Darker colours represent a
higher mortality for the specific age structure and population in that area and time period, a detailed color key is provided in additional file 2.
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The spatial patterns of mortality based on smoothed
small area estimates (Figs. 2, 3, 4 and 5, Additional file 1)
are different for the female cancers and age groups and not
homogenous among the country. No general, significant
coincidence with cantonal or language region borders could
be observed, with the latter additionally being confirmed by
spatial regression for all cancer sites and age groups
(Table 2). The spatial patterns form either sub-cantonal
areas or canton-overspanning areas.
For all cancer sites and age group combinations the model
1 with Poisson distributed data and only one, spatially struc-
tured, random effect was identified as the best model, with
lowest DIC (see Table 3). SMR ratios in the non-spatial
models were close to the results presented in Table 2, and
significance was the same for all but 4 out of 84 coefficients,
with their CIs being close to zero in both models.
Discussion
Using modern Bayesian small area modelling and mapping
techniques we have been able to show that all investigated
groups of women in Switzerland have benefited from pro-
gress in cancer control regardless of place of residence in
the past 40 years. We observed only small differences in
the geographical variation of mortality.
A factor, which may have contributed to breast and
uterine cancer mortality reductions, is the change in the
use of hormone replacement therapy (HRT) [7]. After
an association of HRT use with breast cancer occurrence
was reported [8], its use declined sharply.
We were also not able to show similar spatial patterns
in breast and ovarian cancer mortality although they
share several life style related, environmental and genetic
risk factors. It should be noted however, that hereditary
cancer accounts only for about 5-10 % of the cases in
breast cancer [9] and about 15 % in ovarian cancer [10].
They are shown to occur at younger age and more ad-
vanced stage; still, a visible effect on the mortality map
may only be seen in areas with ethnic groups or very
large families with a highly elevated risk for hereditary
cancer. Such a risk has been described for Ashkenazi
Fig. 3 Trends and geographical distribution of age standardized cervical cancer mortality (SMR) by age group and among selected time periods.
Values are calculated and smoothed in relation to the cancer site and age specific all period combined mortality. Darker colours represent a
higher mortality for the specific age structure and population in that area and time period, a detailed color key is provided in additional file 2.
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Jewish women. The BRCA Ashkenazi founder gene muta-
tions are prevalent in approximately 2 % of these women
[11] with communities of Ashkenazi mainly found in
urban areas; largest communities are in the cities of Zür-
ich, Geneva and Basel contributing to 1-2 % of the popula-
tion [12, 13]. However, the breast and ovarian cancer risk
in BRCA carriers is affected by genetic modifiers and non-
genetic factors, for example, reproductive behaviour, hor-
monal exposure, lifestyle and risk reduction surgeries
[14]. We could not observe an elevated mortality for
the three cities in contrast to the surrounding area
and it remains unclear to which extent the mortality
rates are driven by these hereditary forms of cancer.
Considerable differences in health and health related be-
haviour have been reported for the Swiss language regions
including alcohol intake, smoking and a healthy diet [15, 16]
but lacked significance as regression factors in our analysis.
Only for three cancer site-age group combinations was
the urbanisation level identified as a significant factor.
Urbanisation is serving as a proxy for access to and
quality of medical services, education and health con-
sciousness [3]. By our regression with 20 years of new
data, we could not formally confirm an urban–rural gra-
dient for breast cancer as described by Schüler & Bopp
[3] as significant.
Overall, no general pattern across age groups or can-
cer sites was present.
The reduction of mortality was stronger in the youn-
ger age groups, which is probably the result of better
survival and therefore a shift in the age of death. This
would also explain the temporary increase in breast and
ovarian cancer death risk around the year 1990 in the 75
+ year olds. In addition, in this age group multi-morbid
conditions and fewer treatments are common [17]. Sant
et al. [18] noted that poor survival for gynaecological
cancers in the elderly could be due to advanced stage at
diagnosis, or failure to give adequate treatment, perhaps
because of comorbidity. In general, the interpretability of
results in this age group is limited due to its small size,
more multi-morbid conditions together with possible in-
consistencies in death certification over time, because of
only allowing one single cause of death.
Strengths and limitations
As cancer deaths are rare events and in order to increase
the power, different geographical units have been used
when analysing cancer mortality data in the past. Some
authors have used selected cantons [2] and Schüler &
Bopp [3] used for their cancer atlas somewhat smaller
mobility regions based on the accessibility to goods and
services but which do not take into account population
size. As a result, this choice was too aggregated for some
urban areas and not aggregated enough for some sparsely
populated areas in order to reveal robust, underlying
Fig. 4 Trends and geographical distribution of age standardized uterine cancer mortality (SMR) by age group and among selected time periods.
Values are calculated and smoothed in relation to the cancer site and age specific all period combined mortality. Darker colours represent a
higher mortality for the specific age structure and population in that area and time period, a detailed color key is provided in additional file 2.
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trends. In view that the choice of the geographical unit of
analysis may greatly influence results [19], the combin-
ation of small geographical units with a state-of-the art
smoothing technique enabled a more detailed analysis.
With this analysis, we could additionally show the driving
age groups or subareas of elevated or reduced mortality in
certain regions, while reducing uncertainties due to small
numbers and adding an investigation of non-linear time
trends.
In general, smoothing allows an estimation of the
underlying risk, in a sort of a long-year average, rather
than the actual situation. However, for single municipal-
ities, without fully eliminating it, the use of Bayesian
smoothing reduces the probability to detect narrow
Fig. 5 Trends and geographical distribution of age standardized ovarian cancer mortality (SMR) by age group and among selected time periods.
Values are calculated and smoothed in relation to the cancer site and age specific all period combined mortality. Darker colours represent a
higher mortality for the specific age structure and population in that area and time period, a detailed color key is provided in additional file 2.
Table 3 Model selection based on Deviance Information Criterion (DIC)
Deviance Information Criterion (DIC)
Age group <55 55-74 75+ <55 55-74 75+ <55 55-74 75+ <55 55-74 75 N
Model Breast cancer Uterine cancer Cervical cancer Ovarian cancer
1: P/1re 13,430 20,328 18,161 2,140 8,521 8,327 4,300 5,459 4,167 5,417 11,887 9,404
2: NB/1re 13,462 20,373 18,216 2,149 8,542 8,345 4,312 5,473 4,179 5,430 11,912 9,432
3: P/2re 13,457 20,371 18,212 2,142 8,539 8,345 4,309 5,469 4,180 5,431 11,920 9,424
4: NBN2re 13,494 20,428 18,275 2,149 8,562 8,371 4,325 5,488 4,196 5,449 11,951 9,457
Lowest DIC values per cancer site and age group are highlighted in bold face. Models 1 and 3 are Poisson regression models (P), models 2 and 4 negative
binomial (NB). Models 1 and 2 have one spatially structured random effect (re), models 3 and 4 an additional, unstructured random effect
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areas with specifically high or low risk. Municipalities at
the country border may not benefit from smoothing to
the same extent as municipalities in the interior of the
country due to unknown data on the other side of the
border. Therefore, in the interpretation of the results
emphasis should be given to the broader spatial patterns
rather than to single municipalities.
Comparing with the previous work of Schüler & Bopp [3]
our study not only extended their work by 20 more years
and corrected for non-linear time effects, more importantly,
we were able to correct the foreseen overestimation in mor-
tality numbers until 1994, which could not be adequately
addressed earlier. Priority rules in the coding of causes of
death led to an overestimation in cancer deaths due to their
prioritization over other comorbidities. The applied meth-
odology of age standardisation takes advantage of the actual
age structure rather than a standard population.
There are important limitations to our study. Risk fac-
tors affect incidence but are not necessarily linked to
mortality [20]. The progression stage of the tumours and
their histological type could not be taken into account, as
the ICD-classification does not include histological type
for the sites studied. The regional case mix and its changes
over time therefore may have distorted the results.
Further distortions may arise from the uncertainty as
to what level the reported main cause of death and co-
morbidities are comparable in time and between regions,
although the central coding speaks in favour of a certain
homogeneity in the coding procedure. In the elderly
with frequent multi-morbid conditions, the probability
of misclassification is higher.
Furthermore, after prior analysis the covariates lan-
guage region and urbanisation level were fixed in time
for the municipalities, so that varying developments
therein may have resulted in inaccuracies.
Conclusions
Female gender related cancer mortality continuously de-
creased in Switzerland. In most age groups, this decline
was significant and quite strong in the past decades, result-
ing in values more than 6 times lower within 40 years. The
strongest reduction of mortality was observed for cervical
cancer, followed by uterine, ovarian and breast cancer.
Geographical differences are small and do not follow
cantonal borders. Spatial patterns were different for each
cancer site and age group. The reasons for these differ-
ences are manifold, rising awareness, major advances in
cancer therapy and ongoing developments in the field
had a major impact on the cancer mortality.
Information on the geographical patterns and temporal
trends of the disease burden at different regional scales
are important for the design, implementation and evalu-
ation of programs for cancer control. Access to specialized
medical facilities should be increased especially in high
priority areas in order to further reduce disparities. How-
ever, existing disparities are small.
Appendix
Appendix model formulations
Observed age and cancer site-specific counts of deaths
Yit in municipality i(i = 1,…,N) in period t to follow a
poisson distribution Yit ~ Pois(μit). Age and cancer spe-
cific random effects as well as possible non-linear trends
were modelled on the log of the mean Age Standardized
Mortality Ratio (SMR).
log μitð Þ ¼ log Eitð Þ þ αþ XTij βs þΦi
where Eit is the age and cancer specific expected number of
deaths, Xis the vector of covariates s related to municipality
i and βs the coefficients of associated covariates. Time
periods are included as covariates. Spatial correlation by
age and cancer specific random effects Φi on municipality
level i, modelled via a Conditional Autoregressive (CAR)
process. Spatial dependency among the municipalities was
introduced by the conditional prior distribution of Φi with
Φi eN
γ
X
q ¼ 1
q≠i
N ciqΦq
wi
;
σ2
wi
1
CCCCCCA
0
BBBBBBB@
where ciq characterizes the degree of spatial influence of
municipality i to the remaining municipalities, γ quanti-
fying the overall spatial dependence and wi being the
number of neighbours of municipality i. We used the in-
trinsic version of this CAR model as proposed by Besag,
York and Mollie (1991) where ciq takes the value 1 if mu-
nicipalities are adjacent and 0 otherwise, and γ being equal
to one. As further prior distributions we used:
1
σ2 eΓ 2:01; 1:01ð Þ ; αeU −∞;þ∞ð Þ ; βseN 0; 0:01ð Þ
Additional files
Additional file 1: Detailed Figures of SMR development by cancer
sites and age groups. Development of age standardized breast (Figures
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